NewGenIvf Group Limited
NIVF · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.31 | -53.04 | -0.00 | 0.00 |
| FCF Yield | -18.04% | -0.33% | -0.12% | 0.28% |
| EV / EBITDA | 2,006.35 | 1,440.02 | 713.81 | 851.31 |
| Quality | ||||
| ROIC | -32.65% | 1.11% | -0.42% | -1,594.27% |
| Gross Margin | 33.63% | 32.75% | 25.87% | 24.89% |
| Cash Conversion Ratio | 17.43 | -13.57 | -1.05 | -10.34 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.95% | 7.64% | 1,811,349.65% | 1,602,759.47% |
| Free Cash Flow Growth | -353.01% | -195.38% | -143.88% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 106.02 | 0.72 | 0.55 | 1.53 |
| Interest Coverage | -1.49 | 0.91 | -6.49 | 2.25 |
| Efficiency | ||||
| Inventory Turnover | 44.62 | 27.36 | 93.92 | 74.94 |
| Cash Conversion Cycle | 35.42 | 32.02 | 137.93 | 65.84 |